 This trial will be a double-blind, randomized, placebo-controlled, safety, tolerability and efficacy trial of SAN007 5 East Indian sandalwood oil in a cream formulation treatment regimen when administered daily for up to 28 days to patients from 3 months to 65 years of age, with atopic dermatitis. 